NCT02542969View on ClinicalTrials.gov

Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Healthy
Interventions
DRUG

Simvastatin

DRUG

Rosuvastatin

DRUG

MGL-3196

Trial Locations (1)

85283

Celerion, Tempe

Sponsors

Collaborators (1)

Celerion
All Listed Sponsors
collaborator

Celerion

INDUSTRY

lead

Madrigal Pharmaceuticals, Inc.

INDUSTRY